(Q43718354)

26 November 2017

title

Treatment of the agitation of late-life psychosis and Alzheimer's disease (English)

1 reference

26 November 2017

0 references

1 reference

Salzman C

1

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 January 2001

1 reference

26 November 2017

1 reference

26 November 2017

volume

16 Suppl 1

1 reference

26 November 2017

page(s)

25s-28s

1 reference

Extrapyramidal side effects in a patient treated with risperidone plus donepezil

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900525-3

7 January 2021

Changes in antipsychotic drug use in nursing homes during implementation of the OBRA-87 regulations

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900525-3

7 January 2021

The impact of OBRA on medical practice within nursing facilities

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900525-3

7 January 2021

Donepezil improves symptoms of delirium in dementia: implications for future research

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900525-3

7 January 2021

Neuroleptics in the elderly: guidelines for monitoring

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900525-3

7 January 2021

A randomized, placebo-controlled dose-comparison trial of haloperidol for psychosis and disruptive behaviors in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900525-3

7 January 2021

Incidence and risk factors for severe tardive dyskinesia in older patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900525-3

7 January 2021

10.1016/S0924-9338(00)00525-3

Identifiers

DOI

1 reference

release_mn3q2dur2revnpurk2yf6ei6km

26 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/mn3q2dur2revnpurk2yf6ei6km

24 November 2022

mapped directly with Wikidata item

1 reference